Ken Fisher’s Collegium Pharmaceutical COLL Stock Holding History

Ken Fisher’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58,742	Closed	-$1.26M	–	1185
2023 Q2	$1.26M	Hold	58,742	–	–	﹤0.01%	730
2023 Q1	$1.41M	Sell	58,742 -6,477	-10%	-$172K	﹤0.01%	708
2022 Q4	$1.51M	Hold	65,219	–	–	﹤0.01%	697
2022 Q3	$1.04M	Hold	65,219	–	–	﹤0.01%	659
2022 Q2	$1.16M	Buy	65,219 +14,800	+29%	+$249K	﹤0.01%	609
2022 Q1	$1.03M	Buy	50,419 +10,826	+27%	+$205K	﹤0.01%	626
2021 Q4	$740K	Buy	39,593 +19,244	+95%	+$375K	﹤0.01%	689
2021 Q3	$402K	Buy	20,349 +5,254	+35%	+$114K	﹤0.01%	761
2021 Q2	$357K	Hold	15,095	–	–	﹤0.01%	777
2021 Q1	$358K	Hold	15,095	–	–	﹤0.01%	754
2020 Q4	$302K	Sell	15,095 -5,755	-28%	-$112K	﹤0.01%	791
2020 Q3	$434K	Sell	20,850 -6,756	-24%	-$122K	﹤0.01%	684
2020 Q2	$483K	Sell	27,606 -8,138	-23%	-$159K	﹤0.01%	659
2020 Q1	$584K	Hold	35,744	–	–	﹤0.01%	601
2019 Q4	$736K	Hold	35,744	–	–	﹤0.01%	622
2019 Q3	$410K	Hold	35,744	–	–	﹤0.01%	709
2019 Q2	$470K	Hold	35,744	–	–	﹤0.01%	676
2019 Q1	$541K	Hold	35,744	–	–	﹤0.01%	636
2018 Q4	$614K	Hold	35,744	–	–	﹤0.01%	640
2018 Q3	$527K	Sell	35,744 -13,052	-27%	-$231K	﹤0.01%	644
2018 Q2	$1.16M	Sell	48,796 -11,746	-19%	-$289K	﹤0.01%	570
2018 Q1	$1.55M	Buy	+60,542	New	+$1.44M	﹤0.01%	541

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Ken Fisher's COLL Position: Q3 2023 in Review

Ken Fisher sold out of Collegium Pharmaceutical (COLL) in Q3 2023, closing a stake of 58,742 shares — an estimated $1.26M sold.

Ken Fisher first reported a position in COLL in Q1 2018 and held it in 22 quarters. The position peaked at $1.55M in Q1 2018. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

Ken Fisher reported no remaining Collegium Pharmaceutical position as of Q3 2023 after selling out during the quarter.
Ken Fisher sold 58,742 Collegium Pharmaceutical shares in Q3 2023, an estimated $1.26M.
Ken Fisher first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 22 quarters.
Ken Fisher's Collegium Pharmaceutical position peaked at $1.55M in Q1 2018.
174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.